1-14 of 14
The Corticosteroid Journey in PMR: Understanding the Patient Experience
Medical Industry FeatureThe Corticosteroid Journey in PMR: Understanding the Patient Experience
Charles Turck, PharmD, BCPS, BCCCP
Rodney Daniel, MD
Grace C Wright, MD, PhD, FACR
Expanding Treatment Options in PNH: Expert Approaches to Personalized Care
Medical Industry FeatureExpanding Treatment Options in PNH: Expert Approaches to Personalized Care
Caroline Piatek, MD
Bhumika Patel, MD
Long-Term PNH Management: Addressing Treatment Goals Beyond Symptom Control
Medical Industry FeatureLong-Term PNH Management: Addressing Treatment Goals Beyond Symptom Control
Arati Chand, MD
Bhumika Patel, MD
Understanding the Mechanism Behind a Treatment Approach in Indolent Systemic Mastocytosis (ISM)
Medical Industry FeatureUnderstanding the Mechanism Behind a Treatment Approach in Indolent Systemic Mastocytosis (ISM)
Challenging Cases in IgA Nephropathy and Identifying Patients for Specialized Care
Medical Industry FeatureChallenging Cases in IgA Nephropathy and Identifying Patients for Specialized Care
Jaimini Patel, PharmD, BCCCP
Sayna Norouzi, MD
Rewiring Your Thinking in Paroxysmal Nocturnal Hemoglobinuria
Medical Industry FeatureRewiring Your Thinking in Paroxysmal Nocturnal Hemoglobinuria
Steve Stone, PA-C
George Yaghmour, MD
- advertisement
Moving Beyond Hesitation: Exploring an Oral Option for Managing PNH
Medical Industry FeatureMoving Beyond Hesitation: Exploring an Oral Option for Managing PNH
Steve Stone, PA-C
Jamile Shammo, MD, FASCP, FACP
Personalizing PNH Care: Exploring the Role of Iptacopan in Clinical Practice
Medical Industry FeaturePersonalizing PNH Care: Exploring the Role of Iptacopan in Clinical Practice
Steve Stone, PA-C
Srinivasa Sanikommu, MD
Navigating IgA Nephropathy: Pathogenesis, The Role Of APRIL & The 4-Hit Process, & A Patient Case Study
Medical Industry FeatureNavigating IgA Nephropathy: Pathogenesis, The Role Of APRIL & The 4-Hit Process, & A Patient Case Study
Abigail Yancey, PharmD, BCPS
Kartik Kalra, MD
Expert Opinions on Characteristics of Patients With C3G at High Risk of Progression
Medical Industry FeatureExpert Opinions on Characteristics of Patients With C3G at High Risk of Progression
Dana Rizk, MD
Carla Nester, MD
Sanjeev Sethi, MD, PhD
Leal Herlitz, MD
Expert Opinions on Characteristics of Patients With IgA Nephropathy (IgAN) at High Risk of Progression
Medical Industry FeatureExpert Opinions on Characteristics of Patients With IgA Nephropathy (IgAN) at High Risk of Progression
Dana Rizk, MD
Carla Nester, MD
Sanjeev Sethi, MD, PhD
Leal Herlitz, MD
Expert Opinions on Renal Compensation and Renal Functional Reserve
Medical Industry FeatureExpert Opinions on Renal Compensation and Renal Functional Reserve
Jai Radhakrishnan, MD
Leal Herlitz, MD
- advertisement
Biomarker Predicts Response to BCMA CAR T-Cell Therapy in Multiple Myeloma
Medical Industry FeatureBiomarker Predicts Response to BCMA CAR T-Cell Therapy in Multiple Myeloma
Mateo Mejia Saldarriaga, M.D.
Newborn Gene Sequencing: Expanding Early Detection of Treatable Diseases
Medical Industry FeatureNewborn Gene Sequencing: Expanding Early Detection of Treatable Diseases
Joshua Milner, M.D.
Eric Silver, M.D.
Steven Lobritto, M.D.
